Medicare Enrolled

Dr. James Francesconi, MD

Neurology · Southlake, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
109 RIVER OAKS DR STE 150, Southlake, TX 76092
8173799922
In practice since 2008 (17 years)
NPI: 1326209800 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Francesconi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Francesconi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Francesconi

Dr. James Francesconi is a neurology in Southlake, TX, with 17 years in practice. Based on federal Medicare data, Dr. Francesconi performed 21,069 Medicare services across 296 unique beneficiaries.

Between the years covered by Open Payments, Dr. Francesconi received a total of $14,546 from 64 pharmaceutical and/or device companies across 831 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Francesconi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice▲ Top 4% volume in TX$ $14,546 industry payments

Medicare Practice Summary

Medicare Utilization ↗
21,069
Medicare services
Top 4% in TX for neurology
296
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,239 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Inclisiran injection (Leqvio) for cholesterol20,732$9$42
Drug injection, under skin or into muscle188$11$29
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less52$36$127
Office visit, established patient (30-39 min)34$92$227
Office visit, established patient, complex (40-54 min)34$130$221
New patient office visit, complex (60-74 min)29$160$408
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
99.3% medium
0.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$14,546
Total received (2018-2024)
Avg $2,078/year across 7 years
Top 22% in TX for neurology
64
Companies
831
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,546 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,978
2023
$4,741
2022
$3,511
2021
$1,652
2020
$286
2019
$237
2018
$141

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$2,548
IMPEL PHARMACEUTICALS INC.
$985
PFIZER INC.
$877
EMD Serono, Inc.
$865
Lundbeck LLC
$730
Teva Pharmaceuticals USA, Inc.
$709
Amgen Inc.
$674
Lilly USA, LLC
$630
UCB, Inc.
$571
Biogen, Inc.
$503
Novartis Pharmaceuticals Corporation
$449
UPSHER-SMITH LABORATORIES LLC
$437
SK Life Science, Inc.
$417
Genentech USA, Inc.
$364
Biohaven Pharmaceutical Holding Company Ltd.
$337
MDD US Operations, LLC
$253
Allergan, Inc.
$231
ACADIA Pharmaceuticals Inc
$225
Biohaven Pharmaceuticals, Inc.
$181
AbbVie Inc.
$169
ARGENX US, INC.
$149
Abbott Laboratories
$146
MITSUBISHI TANABE PHARMA AMERICA, INC.
$135
Celgene Corporation
$135
CSL Behring
$114
Neurelis, Inc.
$110
Takeda Pharmaceuticals U.S.A., Inc.
$108
Eisai Inc.
$104
Neurocrine Biosciences, Inc.
$97
Alexion Pharmaceuticals, Inc.
$92
Merz Pharmaceuticals, LLC
$70
Azurity Pharmaceuticals, Inc.
$69
Boston Scientific Corporation
$66
Medtronic, Inc.
$63
HARMONY BIOSCIENCES LLC
$60
Mallinckrodt Hospital Products Inc.
$56
Avanir Pharmaceuticals, Inc.
$54
AQUESTIVE THERAPEUTICS, INC.
$52
Harmony Biosciences LLC
$50
Kyowa Kirin, Inc.
$45
GENZYME CORPORATION
$44
Alnylam Pharmaceuticals Inc.
$43
Amneal Pharmaceuticals LLC
$37
CATALYST PHARMACEUTICALS, INC.
$37
SCILEX PHARMACEUTICALS INC.
$37
Axsome Therapeutics, Inc.
$32
EISAI INC.
$32
PTC Therapeutics, Inc.
$32
Grifols USA, LLC
$30
Horizon Therapeutics plc
$27
Averitas Pharma Inc.
$27
Otsuka America Pharmaceutical, Inc.
$24
Avion Pharmaceuticals
$23
Alfasigma USA, Inc.
$22
E.R. Squibb & Sons, L.L.C.
$21
Supernus Pharmaceuticals, Inc.
$20
Nevro Corp.
$20
BOSTON SCIENTIFIC CORPORATION
$20
Scilex Pharmaceuticals Inc.
$18
Arbor Pharmaceuticals, Inc.
$16
Currax Pharmaceuticals LLC
$16
Allergan Inc.
$13
Janssen Pharmaceuticals, Inc
$12
Sunovion Pharmaceuticals Inc.
$11
Top 3 companies account for 30.3% of total payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AJOVY · AMPLATZER Occluders · AMYVID · APTIOM · AUSTEDO · AVONEX · Aimovig · Austedo XR · BOTOX · Briviact · DAYBUE · DUOPA · Dhivy · EMFLAZA · EMGALITY · Enspryng · Eprontia · FIRDAPSE · Fycompa · GAMMAGARD · Gamunex-C · General - DBS · Gocovri · HORIZANT · HYQVIA · Hizentra · Horizant · INFINITY · INGREZZA · INTELLIS ADAPTIVESTIM · KESIMPTA · KISUNLA · LEQEMBI · LYVISPAH · Leqembi · MAVENCLAD · Mavenclad · NEXVIAZYME · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · ONZETRA XSAIL · OXTELLAR XR · Ongentys · PAXLOVID · PERCEPT PC BRAINSENSE · PLEGRIDY · Ponvory · QULIPTA · QUTENZA · RADICAVA · REXULTI · RYTARY · Rystiggo · SKYCLARYS · SYMPAZAN · Senza · Sunosi · TOSYMRA · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VERCISE · VUMERITY · VYEPTI · VYVGART · Vercise · WAKIX · XCOPRI · Xeomin · ZAVZPRET · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $69 per 100 Medicare services performed
Looking for a neurology in Southlake?
Compare neurologys in the Southlake area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
244
Per 100K population
11.4
County median income
$81,905
Nearest hospital
TEXAS HEALTH HARRIS METHODIST HOSPITAL SOUTHLAKE
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Francesconi is a mixed practice specialist, with above-average Medicare volume (top 4% in TX), and low-engagement industry engagement, with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Francesconi experienced with inclisiran injection (leqvio) for cholesterol?
Based on Medicare claims data, Dr. Francesconi performed 20,732 inclisiran injection (leqvio) for cholesterol services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Francesconi receive payments from pharmaceutical companies?
Yes. Dr. Francesconi received a total of $14,546 from 64 companies across 831 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Francesconi's costs compare to other neurologys in Southlake?
Dr. Francesconi's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Francesconi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →